Plant ID: NPO2166
Plant Latin Name: Ajania Fruticulosa
Taxonomy Genus: Ajania
Taxonomy Family: Asteraceae
NCBI TaxonomyDB:
99024
Plant-of-the-World-Online:
n.a.
China
Ingredient ID: NPC87125
Ingredient ID: NPC79589
Ingredient ID: NPC76336
Ingredient ID: NPC39793
Ingredient ID: NPC321929
Ingredient ID: NPC311485
Ingredient ID: NPC294852
Ingredient ID: NPC286619
Ingredient ID: NPC286006
Ingredient ID: NPC280249
Ingredient ID: NPC264640
Ingredient ID: NPC253915
Ingredient ID: NPC230301
Ingredient ID: NPC228569
Ingredient ID: NPC226712
Ingredient ID: NPC220490
Ingredient ID: NPC204932
Ingredient ID: NPC203891
Ingredient ID: NPC185721
Ingredient ID: NPC176869
Ingredient ID: NPC169828
Ingredient ID: NPC163524
Ingredient ID: NPC147150
Ingredient ID: NPC147001
Ingredient ID: NPC130235
Ingredient ID: NPC113744
Ingredient ID: NPC110532
Ingredient ID: NPC110481
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Therapeutic Target | Enzyme | BLM | Bloom syndrome protein | P54132 | CHEMBL1293237 |
Therapeutic Target | Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Therapeutic Target | Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Therapeutic Target | Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Therapeutic Target | Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Therapeutic Target | Phosphodiesterase | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 81 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT04983160 | Crossover Clinical Trial, Randomized, Double Blind, Placebo Controlled Trial | chronic kidney disease | Allopurinol (NPC321929) | NP level |
NCT00899431 | Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) | chronic lymphocytic leukemia | Allopurinol (NPC321929) | NP level |
NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia | acute lymphoblastic leukemia | Allopurinol (NPC321929) | NP level |
NCT02279641 | RDEA3170 and Allopurinol Combination Study in Gout Subjects | gout | Allopurinol (NPC321929) | NP level |
NCT00639756 | The Effect of Allopurinol on Insulin Resistance and Blood Pressure | metabolic syndrome | Allopurinol (NPC321929) | NP level |
NCT01609166 | Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome | Hand-foot syndrome | Allopurinol (NPC321929) | NP level |
NCT04550234 | A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol | chronic kidney disease | Allopurinol (NPC321929) | NP level |
NCT04256629 | A Study to Assess the Effect of Verinurad on the Electric Activity of the Heart | chronic kidney disease | Allopurinol (NPC321929) | NP level |
NCT01101035 | Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES) | cardiovascular disease | Allopurinol (NPC321929) | NP level |
NCT00004755 | Allopurinol, Glucantime, or Allopurinol/Glucantime for Cutaneous Leishmaniasis in Brazil | Leishmaniasis | Allopurinol (NPC321929) | NP level |
NCT00039130 | Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia | leukemia;lymphoma | Allopurinol (NPC321929) | NP level |
NCT01109121 | Tranilast Plus Allopurinol in Patients With Moderate to Severe Gout (TAnGO) | hyperuricemia;gout | Allopurinol (NPC321929) | NP level |
NCT00288184 | Uric Acid in Essential Hypertension in Children | essential hypertension | Allopurinol (NPC321929) | NP level |
NCT02500641 | Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout | gout | Allopurinol (NPC321929) | NP level |
NCT00987415 | Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels | heart failure | Allopurinol (NPC321929) | NP level |
NCT04217421 | Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass | congenital heart disease | Allopurinol (NPC321929) | NP level |
NCT01736514 | A Study to Evaluate Safety and Efficacy of Oral Febuxostat in Patients With Gout | gout | Allopurinol (NPC321929) | NP level |
NCT00061945 | Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia | B-cell acute lymphoblastic leukemia | Allopurinol (NPC321929) | NP level |
NCT00430248 | Efficacy and Safety of Oral Febuxostat in Participants With Gout | gout | Allopurinol (NPC321929) | NP level |
NCT02082769 | Safety and Efficacy of Oral Febuxostat in Subjects With Gout | gout | Allopurinol (NPC321929) | NP level |
NCT00607152 | Rasburicase (Fasturtec) Registration Trial | hyperuricemia | Allopurinol (NPC321929) | NP level |
NCT03836599 | A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese Subjects | chronic kidney disease | Allopurinol (NPC321929) | NP level |
NCT01399008 | Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients | gout | Allopurinol (NPC321929) | NP level |
NCT03101800 | Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis | ulcerative colitis | Allopurinol (NPC321929) | NP level |
NCT01451645 | Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol | gout | Allopurinol (NPC321929) | NP level |
NCT02700347 | Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers | tuberculosis | Allopurinol (NPC321929) | NP level |
NCT00288171 | Allopurinol for Renal Transplant Associated Hypertension in Children | hypertension | Allopurinol (NPC321929) | NP level |
NCT02498652 | Phase 2a RDEA3170 and Allopurinol Combination Study in Gout Subjects | gout | Allopurinol (NPC321929) | NP level |
NCT04155918 | Phase 2a Study of AR882 Alone and in Combination With Febuxostat or Allopurinol in Gout Patients | gout | Allopurinol (NPC321929) | NP level |
NCT04052932 | A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout | gout | Allopurinol (NPC321929) | NP level |
NCT04368819 | Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms | angina pectoris | Allopurinol (NPC321929) | NP level |
NCT00819585 | A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study) | gout | Allopurinol (NPC321929) | NP level |
NCT01988402 | Does Allopurinol Prolong a Treated, Acute Gout Flare? | gout | Allopurinol (NPC321929) | NP level |
NCT02129764 | Prednisone for Heart Failure Patients With Hyperuricemia | heart failure | Allopurinol (NPC321929) | NP level |
NCT04532918 | Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers | chronic kidney disease | Allopurinol (NPC321929) | NP level |
NCT03680638 | The Effect of Antioxidants on Skin Blood Flow During Local Heating | cardiovascular disease | Allopurinol (NPC321929) | NP level |
NCT00109837 | S0333 Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | leukemia | Allopurinol (NPC321929) | NP level |
NCT01493531 | Combining Lesinurad With Allopurinol in Inadequate Responders | gout | Allopurinol (NPC321929) | NP level |
NCT03336203 | The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF) | gout | Allopurinol (NPC321929) | NP level |
NCT01724528 | Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies | Tumor Lysis Syndrome | Allopurinol (NPC321929) | NP level |
NCT00276003 | INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma. | non-Hodgkins lymphoma | Allopurinol (NPC321929) | NP level |
NCT01200485 | Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 | leukemia;lymphoma | Allopurinol (NPC321929) | NP level |
NCT02078219 | Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia | gout | Allopurinol (NPC321929) | NP level |
NCT00174915 | Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects. | gout | Allopurinol (NPC321929) | NP level |
NCT00241839 | Uric Acid and Hypertension in African Americans | heart disease;hypertension | Allopurinol (NPC321929) | NP level |
NCT01092221 | Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode | bipolar disorder | Allopurinol (NPC321929) | NP level |
NCT00602693 | T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer | multiple myeloma;myelodysplastic syndrome;leukemia | Allopurinol (NPC321929) | NP level |
NCT01391325 | Allopurinol Outcome Study | gout | Allopurinol (NPC321929) | NP level |
NCT02038179 | Center of Research Translation (CORT) Project 2 | hypertension | Allopurinol (NPC321929) | NP level |
NCT00000658 | A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma | non-Hodgkins lymphoma | Allopurinol (NPC321929) | NP level |
NCT03272425 | Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence. | gout | Allopurinol (NPC321929) | NP level |
NCT03506919 | Comparative Clinical Efficacy and Safety of Coded Polyherbal Medicine for the Management of Arthritis | osteoarthritis | Allopurinol (NPC321929) | NP level |
NCT00102440 | Febuxostat Versus Allopurinol Control Trial in Subjects With Gout | gout | Allopurinol (NPC321929) | NP level |
NCT04327024 | Study of Verinurad in Heart Failure With Preserved Ejection Fraction | heart failure | Allopurinol (NPC321929) | NP level |
NCT01310673 | Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout | gout | Allopurinol (NPC321929) | NP level |
NCT03076684 | Gender Differences in the Metabolic Effects of Uric Acid | hyperuricemia | Allopurinol (NPC321929) | NP level |
NCT00175019 | Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010 | gout | Allopurinol (NPC321929) | NP level |
NCT01459796 | Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares | gout | Allopurinol (NPC321929) | NP level |
NCT03022747 | Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using Allopurinol | acute lymphoblastic leukemia | Allopurinol (NPC321929) | NP level |
NCT03990363 | A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia | chronic kidney disease | Allopurinol (NPC321929) | NP level |
NCT02533648 | Role of Allopurinol on Oxidative Stress and Mitochondrial Alterations in Skeletal Muscle of Diabetic Patients | type 2 diabetes mellitus | Allopurinol (NPC321929) | NP level |
NCT01464359 | T-Cell Depleted Double UCB for Refractory AML | acute myeloid leukemia | Allopurinol (NPC321929) | NP level |
NCT01129648 | Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout | gout | Allopurinol (NPC321929) | NP level |
NCT00230178 | Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome | hyperuricemia;Tumor Lysis Syndrome | Allopurinol (NPC321929) | NP level |
NCT01077284 | Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones | nephrolithiasis | Allopurinol (NPC321929) | NP level |
NCT03680573 | The Effect of Antioxidants on Skin Blood Flow-BH4 | cardiovascular disease | Allopurinol (NPC321929) | NP level |
NCT01320722 | Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function | obesity | Allopurinol (NPC321929) | NP level |
NCT01052272 | Impact of Diabetes on Left Ventricular Remodeling | diabetes mellitus | Allopurinol (NPC321929) | NP level |
NCT03570983 | A Trial Comparing Single Agent Melphalan to Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) as a Preparative Regimen for Patients With Multiple Myeloma Undergoing High Dose Therapy Followed by Autologous Stem Cell Reinfusion | multiple myeloma | Allopurinol (NPC321929) | NP level |
NCT01510158 | Combining Lesinurad With Allopurinol in Inadequate Responders | gout | Allopurinol (NPC321929) | NP level |
NCT01987570 | Effect of Allopurinol Administration on the Prevention of Muscle Mass Loss in Subject Immobilized. | sprain | Allopurinol (NPC321929) | NP level |
NCT00003700 | Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia | leukemia | Allopurinol (NPC321929) | NP level |
NCT04956432 | A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout | gout | Allopurinol (NPC321929) | NP level |
NCT00849368 | Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients | inflammatory bowel disease | Allopurinol (NPC321929) | NP level |
NCT00652899 | Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer | fallopian tube cancer;ovarian cancer;peritoneum cancer | Allopurinol (NPC321929) | NP level |
NCT00053196 | Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer | multiple myeloma;myelodysplastic syndrome;myeloproliferative disorder;leukemia | Allopurinol (NPC321929) | NP level |
NCT01001338 | Allopurinol Combination Study | gout | Allopurinol (NPC321929) | NP level |
NCT02063997 | Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients | gout | Allopurinol (NPC321929) | NP level |
NCT05049863 | Chemotherapy in Patients With Relapsed Small Cell Lung Cancer in Combination With Allopurinol and MycoPhenolate (CLAMP Trial) | small cell lung carcinoma | Allopurinol (NPC321929) | NP level |
NCT00181155 | Intravenous Allopurinol in Heart Failure | congestive heart failure | Allopurinol (NPC321929) | NP level |
NCT02046694 | A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL | acute lymphoblastic leukemia | Allopurinol (NPC321929) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
XDH
NCT03990363,NCT04550234,NCT03836599,NCT04983160,NCT04532918,NCT04256629 |
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
BLM,CA4,CA12,SMN1,F2,XDH,RAB9A
|
LeukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60-2B33 |
NCT00109837,NCT00039130,NCT00003700,NCT01200485,NCT00053196,NCT00602693
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
BLM,CA7,CA12,CA9,F2,XDH
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
CA7,CA12,CA9,SMN1,TDP1,XDH
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
BLM,CA9,CA12,CA4,CA12,CA9
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
BLM,CA7,CA12,CA9,F2,XDH
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
CA9,CA4,XDH,MTOR,CA12
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
BLM,CA12,CA9,SMN1,TDP1
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
BLM,CA7,CA9,F2,XDH
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
BLM,CA4,CA7,CA12,CA9
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
F2
NCT03680573,NCT01101035,NCT03680638 |
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
MTOR
NCT02038179,NCT00288171,NCT00241839 |
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
CA4,CA9,MTOR,CA12
|
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
MTOR
NCT03570983,NCT00602693,NCT00053196 |
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
MTOR,CA9
NCT01200485,NCT00039130 |
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
XDH
NCT04327024,NCT00987415,NCT02129764 |
HyperlipidemiaDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C80 |
NCT03076684,NCT01109121,NCT00607152,NCT00230178
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
CA7,TDP1,CA9,XDH
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
CA12,CA9,TDP1,XDH
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
XDH,CA9,F2,CA9
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
BLM,CA9,F2,XDH
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
BLM,CA12,CA9,RAB9A
|
Precursor cell lymphoblastic leukaemia, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5J37 |
NCT03150693,NCT03022747,NCT02046694
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
BLM,XDH,CA4
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
BLM,CA4,CA9
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
BLM,CA12,CA4
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
CA12,XDH,CA9
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
CA7,XDH,CA12
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
BLM,CA9,CA12
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
XDH
NCT01988402,NCT01736514,NCT00175019,NCT01129648,NCT02082769,NCT04155918,NCT00819585,NCT04956432,NCT00174915,NCT01459796,NCT00102440,NCT00430248,NCT01391325,NCT02500641,NCT03336203,NCT02078219,NCT01510158,NCT01109121,NCT02498652,NCT01399008,NCT01310673,NCT04052932,NCT03272425,NCT02279641,NCT01493531,NCT02063997,NCT01001338,NCT01451645 |
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
CA12,CA4
|
Muscular atrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B61 |
SMN2,SMN1
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
F2,CA4
|
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
CA9,MTOR
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
F2
NCT02533648 |
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
CA12,CA4
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
F2
NCT04368819 |
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
NCT00602693,NCT00053196
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT00276003,NCT00000658
|
Tumour lysis syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5D01 |
NCT01724528,NCT00230178
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
BLM
NCT00004755 |
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
BLM,F2
|
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
F2,CA9
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
F2,CA4
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
CA9,F2
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
RAB9A,CA4
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
BLM,CA9
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
XDH
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
MTOR
|
Pleural mesotheliomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26 |
MTOR
|
Nutritional deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B50-5B71 |
F2
|
EncephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E47 |
XDH
|
Bleeding disorderDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA20-GA21 |
F2
|
Coagulation defectDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B10 |
F2
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
MTOR
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
F2
|
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
MTOR
|
Inborn purine/pyrimidine/nucleotide metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C55 |
XDH
|
Metastatic lymph node neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60 |
MTOR
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
MTOR
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
MTOR
|
Coronary thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA43 |
F2
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
MTOR
|
Cerebral ischaemic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B11 |
F2
|
Mineral deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B5K |
XDH
|
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
MTOR
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
MTOR
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
MTOR
|
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
F2
|
Arteries/arterioles disorderDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD52 |
MTOR
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
RAB9A
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
F2
|
ThrombosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB61-GB90 |
F2
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
MTOR
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
F2
|
Malignant mesenchymal neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D-2B5Y |
MTOR
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
MTOR
|
LymphangioleiomyomatosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB07 |
MTOR
|
HydrocephalusDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D64 |
MTOR
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
MTOR
|
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
CA4
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
NCT00849368
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
NCT00053196
|
Essential hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00 |
NCT00288184
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
NCT00652899
|
Burkitt-like lymphoma with 11q aberrationDisease Category: X.Extension CodesDisease ICD-11 Code: XH8NN2 |
NCT00061945
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
NCT00241839
|
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
NCT01464359
|
Chronic lymphocytic leukaemia or small lymphocytic lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82.0 |
NCT00899431
|
ObesityDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B80-5B81 |
NCT01320722
|
Structural developmental anomaly of heart or great vessels, unspecifiedDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA8Z |
NCT04217421
|
CholelithiasisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DC11 |
NCT01077284
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT03506919
|
Congestive heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10 |
NCT00181155
|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
NCT00652899
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
NCT00639756
|
Other specified syndromes with multiple structural anomalies, not of environmental originDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2F.1Y |
NCT01609166
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
NCT01052272
|
Ulcerative colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD71 |
NCT03101800
|
Small cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.1 |
NCT05049863
|
Strain or sprain of ankleDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND14.7 |
NCT01987570
|
Malignant neoplasms of retroperitoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C50 |
NCT00652899
|
Bipolar disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60 |
NCT01092221
|
HIV-infected patients with tuberculosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1B10-1B14 |
NCT02700347
|
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
CA12
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
CA7
|
KeratoconusDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A78.50 |
CA4
|
Pre-eclampsiaDisease Category: 18.Pregnancy, childbirth or the puerperiumDisease ICD-11 Code: JA24 |
CA4
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
BLM
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
KDM4E
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
CA9
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
XDH
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
CA9
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
CA12
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
BLM
|